Hyderabad-based Aragen partners with Skyhawk Therapeutics
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions. It will help accelerate Skyhawk’s research pipeline.
Hyderabad: Aragen Life Sciences (formerly GVK Bio), Hyderabad-based contract research and development organisation (CRDO), partnered with US-based Skyhawk Therapeutics, a company that develops small molecule therapeutics that correct RNA expression.
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions. It will help accelerate Skyhawk’s research pipeline.
“At Aragen, we believe that in every molecule there is the possibility for better health. It is with this spirit that we look forward to leveraging Aragen’s 20 years of discovery research expertise to help Skyhawk advance the development of its novel small molecule therapeutics targeting some of the world’s most intractable diseases,” said Manni Kantipudi, CEO of Aragen.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
